How should prostate specific antigen be interpreted? - Wikidata - wikimedia - TriplyDB

How should prostate specific antigen be interpreted?

How should prostate specific antigen be interpreted?

http://www.wikidata.org/entity/Q35993964

about

Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population.

P2860

Q37553969-D3A5C5B6-AABC-4128-8C3D-13010C031F79

P2860

How should prostate specific antigen be interpreted?

http://www.wikidata.org/entity/Q35993964

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

How should prostate specific antigen be interpreted?

@ast

How should prostate specific antigen be interpreted?

@en

type

label

How should prostate specific antigen be interpreted?

@ast

How should prostate specific antigen be interpreted?

@en

prefLabel

How should prostate specific antigen be interpreted?

@ast

How should prostate specific antigen be interpreted?

@en

P1433

Q35993964-D969BED7-FB34-457F-820C-789C8F4BFBCF

P1476

Q35993964-960E91EF-6AD1-4E29-B15A-FF0FB6115EA0

P2093

Q35993964-3D796D5C-BDFD-4338-AB3B-C5BC8CAE90DE

Q35993964-D9AF8A63-44F5-493E-9B7D-F98B65217392

P2860

Q35993964-001907B1-CBDE-4652-BDF2-524612E78F7D

Q35993964-0C2B65AF-EC46-48D0-8EF6-957ED5227E6A

Q35993964-1362C7B4-4D27-4E95-9FE1-CAD637393832

Q35993964-1F634D6C-A193-4A6E-B8AB-2697DF2D231D

Q35993964-212ED9CF-F025-4146-944B-79EE59EBF4F8

Q35993964-2295B802-2CA0-4298-A6C6-00DF8FD5B2B1

Q35993964-257ECAD9-45E7-4DF5-AB8E-11FBB29DE190

Q35993964-345F11DC-8848-4477-9426-5DFD52DE7734

Q35993964-4195F286-4D67-40C3-80E8-CDF42F3FD3DD

Q35993964-53C1A07C-1A9F-4A0E-869F-65BC5F15B1E3

P304

Q35993964-5CC142BA-315D-4BDD-B0E3-FCC266B75F6C

P31

Q35993964-762C8DB1-DB09-4CB2-93A6-125F64CEE5CC

P356

Q35993964-A98E6260-EFBC-42EB-A0E1-D91F025A75F9

P433

Q35993964-1FAE4F55-43CE-4440-8757-7B7BBF4BD984

P478

Q35993964-2416F70E-069A-4E9F-89E3-00557D41EEA0

P577

Q35993964-37A9062A-9FFF-4F9B-9DFC-005C07C3732B

P5875

Q35993964-504C90A7-84AC-4397-8691-9669DA6C0B21

P698

Q35993964-1722C136-A234-4D44-A952-9387DA81B41C

P932

Q35993964-9991499F-3986-4605-877D-05ACF8C5C928

P356

P1433

Turkish Journal of Urology

P1476

How should prostate specific antigen be interpreted?

@en

P2093

Ali Atan

http://www.w3.org/2001/XMLSchema#string

Özer Güzel

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005

Cancer statistics, 2010

American Cancer Society guideline for the early detection of prostate cancer: update 2010

Prostate specific antigen best practice statement: 2009 update

Randomised prostate cancer screening trial: 20 year follow-up

Screening and prostate-cancer mortality in a randomized European study

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.

Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit.

P304

188-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5152/TUD.2013.038

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273360930

http://www.w3.org/2001/XMLSchema#string

P698

26328106

http://www.w3.org/2001/XMLSchema#string

P932

4548626

http://www.w3.org/2001/XMLSchema#string